US Bancorp DE Purchases 1,343 Shares of Simulations Plus, Inc. (NASDAQ:SLP)

US Bancorp DE grew its stake in shares of Simulations Plus, Inc. (NASDAQ:SLP) by 37.0% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,974 shares of the technology company’s stock after buying an additional 1,343 shares during the period. US Bancorp DE’s holdings in Simulations Plus were worth $159,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Congress Asset Management Co. increased its position in shares of Simulations Plus by 22.5% during the 3rd quarter. Congress Asset Management Co. now owns 206,542 shares of the technology company’s stock valued at $6,613,000 after purchasing an additional 37,914 shares during the last quarter. Semanteon Capital Management LP purchased a new position in shares of Simulations Plus in the third quarter valued at about $358,000. Tributary Capital Management LLC raised its holdings in shares of Simulations Plus by 54.7% during the third quarter. Tributary Capital Management LLC now owns 325,567 shares of the technology company’s stock valued at $10,425,000 after acquiring an additional 115,122 shares in the last quarter. Trust Point Inc. lifted its position in shares of Simulations Plus by 27.5% in the 3rd quarter. Trust Point Inc. now owns 11,994 shares of the technology company’s stock worth $384,000 after purchasing an additional 2,589 shares during the period. Finally, nVerses Capital LLC grew its holdings in shares of Simulations Plus by 1,100.0% during the 3rd quarter. nVerses Capital LLC now owns 1,200 shares of the technology company’s stock worth $38,000 after acquiring an additional 1,100 shares during the period. Hedge funds and other institutional investors own 78.08% of the company’s stock.

Simulations Plus Trading Down 3.2 %

Shares of NASDAQ SLP opened at $28.77 on Friday. The firm’s 50-day moving average price is $31.31 and its 200-day moving average price is $39.04. Simulations Plus, Inc. has a 12-month low of $27.22 and a 12-month high of $51.22. The stock has a market capitalization of $577.41 million, a price-to-earnings ratio of 58.72 and a beta of 0.71.

Simulations Plus (NASDAQ:SLP) last announced its earnings results on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. The business had revenue of $18.70 million for the quarter, compared to the consensus estimate of $19.73 million. Simulations Plus had a net margin of 14.15% and a return on equity of 6.16%. The business’s revenue for the quarter was up 19.9% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.18 earnings per share. On average, equities analysts predict that Simulations Plus, Inc. will post 1.12 EPS for the current fiscal year.

Analyst Ratings Changes

SLP has been the topic of a number of recent research reports. StockNews.com cut Simulations Plus from a “hold” rating to a “sell” rating in a research note on Monday, November 4th. Stephens assumed coverage on shares of Simulations Plus in a report on Friday. They issued an “overweight” rating and a $39.00 price objective on the stock. KeyCorp began coverage on Simulations Plus in a report on Monday, July 29th. They set an “overweight” rating and a $47.00 price target for the company. William Blair restated an “outperform” rating on shares of Simulations Plus in a research note on Wednesday, November 6th. Finally, BTIG Research dropped their price target on Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the company. According to MarketBeat, Simulations Plus presently has a consensus rating of “Moderate Buy” and an average target price of $51.40.

Insider Buying and Selling at Simulations Plus

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Tuesday, October 1st. The stock was sold at an average price of $31.26, for a total transaction of $625,200.00. Following the completion of the sale, the director now directly owns 3,481,592 shares of the company’s stock, valued at $108,834,565.92. The trade was a 0.57 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders have sold 60,750 shares of company stock valued at $1,905,655 in the last quarter. 20.90% of the stock is owned by insiders.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.